Deciphering the Genetics of Cardiovascular Disease

The Guo Lab studies the genetic and epigenetic mechanisms of cardiovascular disease and cardiac development, using CRISPR screening and editing, single-cell sequencing, human iPSC-derived 2D cardiomyocytes and 3D cardiac organoids, animal studies, and bioinformatics, toward precision medicine for cardiovascular disease.

Deciphering Variant Pathogenicity

The Guo Lab works to decipher how pathogenic variants — including variants of uncertain significance — cause cardiovascular disease, combining genetics with CRISPR-edited stem-cell models.

About Guo Lab

Our Research

Featured Publications

Recent publications highlight groundbreaking findings on the genetic mechanisms of heart disease, novel therapeutic approaches for heart failure, and innovative strategies for improving cardiovascular health outcomes.

Mentorship and Training

The Guo Lab welcomes applications for postdoctoral fellow, research assistant, and graduate / MD-PhD student positions. To apply, contact Dr. Hongchao Guo at hongchao.guo@hsc.utah.edu.

Get Involved

Faculty

Hongchao Guo, PhD

Hongchao Guo, PhD

Assistant Professor, Department of Surgery

Dr. Guo earned his PhD in cell biology from Nankai University in 2015, completed postdoctoral training in Dr. Joseph Wu’s lab at the Stanford Cardiovascular Institute, and received an NIH K99/R00 award in 2020.